| Concentration–response relationships of dolutegravir and efavirenz with weight change after starting antiretroviral therapy R Griesel, AN Kawuma, R Wasmann, S Sokhela, G Akpomiemie, ... British journal of clinical pharmacology 88 (3), 883-893, 2022 | 15 | 2022 |
| Population pharmacokinetic model and alternative dosing regimens for dolutegravir coadministered with rifampicin AN Kawuma, RE Wasmann, KE Dooley, M Boffito, G Maartens, P Denti Antimicrobial agents and chemotherapy 66 (6), e00215-22, 2022 | 7 | 2022 |
| Drug–drug interaction between rifabutin and dolutegravir: A population pharmacokinetic model AN Kawuma, RE Wasmann, KE Dooley, G Maartens, P Denti British journal of clinical pharmacology 89 (3), 1216-1221, 2023 | 6 | 2023 |
| Dolutegravir pharmacokinetics during co-administration with either artemether/lumefantrine or artesunate/amodiaquine AN Kawuma, SI Walimbwa, G Pillai, S Khoo, M Lamorde, RE Wasmann, ... Journal of Antimicrobial Chemotherapy 76 (5), 1269-1272, 2021 | 5 | 2021 |
| Pharmacogenetics of dolutegravir plasma exposure among southern Africans with human immunodeficiency virus Z Cindi, AN Kawuma, G Maartens, Y Bradford, F Venter, S Sokhela, ... The Journal of infectious diseases 226 (9), 1616-1625, 2022 | 4 | 2022 |
| Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African population R Griesel, P Sinxadi, A Kawuma, J Joska, S Sokhela, G Akpomiemie, ... Journal of Antimicrobial Chemotherapy 77 (11), 3110-3117, 2022 | 3 | 2022 |
| Pharmacokinetics of antimalarial drugs used to treat uncomplicated malaria in breastfeeding mother-infant pairs: An observational pharmacokinetic study R Nakijoba, AN Kawuma, FW Ojara, JC Tabwenda, J Kyeyune, ... Wellcome open research 8, 2023 | 2 | 2023 |
| Altered drug exposures of first-line TB drugs in a moxifloxacin-containing treatment regimen R Perumal, O Arodola-Oladoyinbo, A Naidoo, AN Kawuma, K Naidoo, ... The International Journal of Tuberculosis and Lung Disease 26 (8), 766-774, 2022 | 2 | 2022 |
| Pharmacogenetics of tenofovir clearance among Southern Africans living with HIV Z Cindi, AN Kawuma, G Maartens, Y Bradford, S Sokhela, N Chandiwana, ... Pharmacogenetics and Genomics 33 (4), 79-87, 2023 | 1 | 2023 |
| Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population AN Kawuma, RE Wasmann, P Sinxadi, SM Sokhela, N Chandiwana, ... CPT: Pharmacometrics & Systems Pharmacology 12 (6), 821-830, 2023 | 1 | 2023 |
| R Based Shiny App To Simulate PKPD Profiles Using TMDD Models AN Kawuma, RM Benecke, S Mouksassi, G Pillai, MT Chirehwa | 1 | |
| Pharmacokinetics of drugs used to treat drug sensitive-tuberculosis in breastfeeding mother-infant pairs: An observational pharmacokinetic study R Nakijoba, AN Kawuma, FW Ojara, JC Tabwenda, J Kyeyune, ... Wellcome Open Research 8 (216), 216, 2024 | | 2024 |
| Determinants of early change in serum creatinine after initiation of dolutegravir‐based antiretroviral therapy in South Africa R Mpofu, AN Kawuma, RE Wasmann, G Akpomiemie, N Chandiwana, ... British Journal of Clinical Pharmacology, 2024 | | 2024 |
| PA-727 Physiologically-based pharmacokinetic modelling of drug-drug interactions between ritonavir-boosted atazanavir and rifampicin in pregnancy S Atoyebi, MC Montanha, L Najjemba, C Orrell, L Jennings, H Mugerwa, ... BMJ Global Health 8 (Suppl 10), 2023 | | 2023 |
| Prevalence and factors associated with suboptimal adherence to dolutegravir-based regimens among people living with HIV in a specialized clinic in Kampala, Uganda E Namakula, H Mugerwa, F Kitutu, AN Kawuma, R Kiguba, JN Kalyango | | 2023 |
| Pharmacokinetics of drugs used to treat uncomplicated malaria in breastfeeding mother-infant pairs: A n observational pharmacokinetic study [version 1; peer review R Nakijoba, AN Kawuma, FW Ojara, JC Tabwenda, J Kyeyune, ... | | 2023 |
| A systematic review on maternal-to-infant transfer of drugs through breast milk during the treatment of malaria, tuberculosis, and neglected tropical diseases FW Ojara, AN Kawuma, C Waitt PLOS Neglected Tropical Diseases 17 (7), e0011449, 2023 | | 2023 |
| A commentary on establishing a local centre of excellence for research and training in Pharmacometrics: Lessons from the Pharmacometrics Africa-Uganda Chapter. L Najjemba, A Kawuma, F Williams, J Arinaitwe, R Kikonyogo, J Mukonzo, ... Authorea Preprints, 2023 | | 2023 |
| Establishing a local centre of excellence for research and training in pharmacometrics: Lessons from the Pharmacometrics Africa-Uganda chapter L Najjemba, A Kawuma, F Williams, B Obura, C Sekaggya-Wiltshire, ... | | 2023 |
| Pharmacometrics of dolutegravir and tenofovir: a quantitative approach to characterise drug-drug interactions, pharmacogenetics and optimise treatment A Kawuma | | 2023 |
